牛磺熊去氧胆酸治疗非酒精性脂肪肝疗效观察

doi:10.3969/j.issn.1672-5069.2014.01.024

Abstract

Zhou Jian, Liu Li, Huang Liwen. Clinical observation of tauroursodeoxycholic acid in treatment of patients with non-alcohol fatty liver[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(1): 80-81.

[1] Mehta K,Van Thiel DH,Shah N,et al. Nonalcoholic fatty liver disease：pathogenesis and the role of antioxidants. Nutr Rev,2002,60（9）：289-293.
[2] 谭彦芳,赵彩彦. 非酒精性脂肪肝药物治疗进展. 实用肝脏病杂志,2013,16（4）：378-381.
[3] 马雄,魏珏. 非酒精性脂肪肝伴发纤维化的研究现状.药品评价,2007,4（4）：282-283.
[4] 中华医学会肝脏病学会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南. 中华肝脏病杂志,2006,14（3）：161-163.
[5] 曹荣,胡旭东,柏涛,等. 熊去氧胆酸与牛磺熊去氧胆酸联合多烯磷脂酰胆碱治疗非酒精性脂肪肝的疗效比较.中国药房,2013,24（4）：365-367.
[6] 张忠勇,祁月英,苏秀海,等. 非酒精性脂肪肝治疗研究进展.现代中西医结合杂志,2012,21（8）：902.
[7] Angulo P. Use of ursodeoxycholic acid in patients with liver disease. Curr Gastroenterol Rep,2002,4：37-42.
[8] 张晓峰,王立福,白云峰,等. 泽泻联合熊去氧胆酸胶囊治疗非酒精性单纯性脂肪肝疗效观察. 中华中医药学刊,2012,30（2）：274.
[9] Tsukahara K,Kanai S,Ohta M,et al. Taurine conjugate of ursodeoxycholate plays a major role in the hepatoprotective effect against cholestasis induced by taurochenodeoxycholate in rats.Liver,1993,13：262-269.
[10] Heuman DM,Bajaj R. Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts. Gastroenterology,1994,106：1333-1341.
[11] 王丹,杨玲,黄金明,等. 牛磺熊去氧胆酸抑制四氯化碳诱导的大鼠肝纤维化. 世界华人消化杂志,2010,18（19）：1979-1980.
[12] Crosignani A,Budillon G,Cimino L,et al. Tauroursodeoxycholic acid for the treatment of HCV-related chronic hepatitis：a multicenter placebo-controlled study. Hepatogastroenterology,1998,45：1624-1629.

[1]	Xing Xin, Wei Zhongcao, Zhou mimi, et al.. Efficacy and safety of tauroursodeoxycholic acid and ursodeoxycholic acid combination in the treatment of patients with nonalcoholic fatty liver disease:a Meta-analysis [J]. Journal of Practical Hepatology, 2019, 22(6): 852-855.
[2]	Zhu Yage, Liu Jinfeng.. Therapeutic efficacy of adenosine methionine and glycyrrhizin combination in treatment of patients with alcoholic cirrhosis and its effect on serum BGP levels [J]. Journal of Practical Hepatology, 2019, 22(6): 872-875.
[3]	Zhao Fangfang, Zhai Yongzhen, Feng Guohe. Efficacy and safety of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 700-703.
[4]	Zhang Zhicheng, Yuan Guangqi, Mo Chanjun. Impact of blood supply on efficacy of hepatic artery embolization in treatment of patients with hepatic hemangioma [J]. Journal of Practical Hepatology, 2019, 22(5): 736-739.
[5]	Yan Lingling, Hu Donghui, Huang Yanfang. Influence of ademetionine combined with polyene phosphatidylcholine on clinical efficacy and laboratory index in patients with intrahepatic cholestasis of pregnancy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 530-533.
[6]	Yuan Chunhui, Li Chunyu, Li Hongli. Efficacy of pegylated interferon α -2b in the treatment of patients with serum HBeAg positive chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 353-356.
[7]	Ma Xiaosu, Pei Renming Zhang Tingting. Comparison of magnetic resonance cholangiopancreatography with color Doppler ultrasound in diagnosis of patients with common bile duct stones [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 433-436.
[8]	Wang Xiuqing, Ma Yanjun, Zhan Jinli. Efficacy of transcatheter arterial chemoembolization and ultrasound-guided microwave ablation in the treatment of patients with hepatocellular carcinoma at special sites [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 260-263.
[9]	Yan Huanjie, Zhang Shuqin, Zhao Wenjing.. Therapeutic efficacy of autologous bone marrow stem cell transplantation for treatment of patients with hepatitis B-induced acute-on-chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 81-84.
[10]	Wang Chan, Qin Wei, Dai Yong, et al.. Clinical efficacy of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 97-100.
[11]	Ma Lyuxiang, Zhang Xuesong.. Efficacy and prognosis of ultrasound-guided percutaneous radiofrequency ablation in treatment of patients with small hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 125-128.
[12]	Hongjie, Zhou Dongfang.. Efficacy of entecavir and Chinese herbal medicine combination therapy in patients with hepatitis B-induced liver cirrhosis An [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 903-906.
[13]	Li Lianhai, Xu Huiling, Wang Jinbang.. Evaluation by CT three dimensional reconstruction in patients with hilar cholangiocarcinoma underwent hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 947-950.
[14]	Ye Xuan, Zhang Peng.. Efficacy of microwave ablation combined with transcatheter arterial chemoembolization in treatment of patients with hepatic metastasis from colorectal cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 955-958.
[15]	Yang Xiaoyong, Li Wenmei, Song Qingwei, et al.. Shor-term efficacy of laparoscopic functional retention operation in patients with pancreatic neuroendocrineneoplasm [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 971-974.

Clinical observation of tauroursodeoxycholic acid in treatment of patients with non-alcohol fatty liver

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments